Kato ET, Silverman MG, Mosenzon O, Zelniker TA, Cahn A, Furtado RHM, Kuder J, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Bonaca MP, Ruff CT, Desai AS, Goto S, Johansson PA, Gause-Nilsson I, Johanson P, Langkilde AM, Raz I, Sabatine MS, Wiviott SD
Ozempic can be used to lower the risk of major cardiovascular events in adults with type 2 diabetes, as well as lower the risk of end-stage kidney disease, sustained eGFR decline (a measure of kidney function), and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
McArthur GA, Puzanov I, Amaravadi R, Ribas A, Chapman P, Kim KB et al
For IBS-like discomfort more broadly, the 2021 American College of Gastroenterology clinical guideline on IBS made a conditional recommendation against the use of probiotics for the treatment of global IBS symptoms, citing very low quality of evidence and substantial heterogeneity across strains, doses, and outcomes.[6] The ACG position is the strongest authoritative reading available